Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Sanofi achieves KEAP1/Nrf2 inhibition with bioavailable small molecules

Sep. 19, 2018

Patient recruitment starts in two phase II trials of DMX-200 in kidney disease

Sep. 18, 2018

Humanized midkine antibody demonstrates efficacy in experimental model of FSGS

Sep. 13, 2018

SuPAR predicts chronic kidney disease progression in Black Americans

Sep. 12, 2018

Daiichi Sankyo discovers bacterial tryptophanase inhibitors

Sep. 10, 2018

BAY-1101042, a potent NO- and heme-independent sGC activator suitable for oral dosing

Sep. 5, 2018

Janssen Pharmaceutica NV synthesizes 5-HT2B receptor antagonists

Sep. 4, 2018

Bristol-Myers Squibb patents receptor-interacting serine/threonine-protein kinase 1 inhibitors

Aug. 31, 2018

Positive topline data presented from phase Ib study of TAR-302 in idiopathic overactive bladder

Aug. 29, 2018

Sunitinib noninferior to nephrectomy in patients with metastatic renal-cell carcinoma

Aug. 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...